Novartis Under Investigation Over MS Drug Marketing
The U.S. government is investigating whether Novartis AG employed illegal marketing practices and provided kickbacks to health care providers for using its multiple sclerosis drug Gilenya, the pharmaceutical company revealed Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article